海南省將中醫藥服務納入海南自貿港新增鼓勵類產業目錄
海南省近日對外公布《關於促進中醫藥在海南自由貿易港傳承創新發展的實施意見》,明確將中醫藥服務納入海南自貿港新增鼓勵類產業目錄,全面推動中醫藥傳承創新發展。
意見提出,海南將中醫藥服務貿易作為全省開展服務貿易創新發展的重點領域進行突破,吸引更多中醫藥服務貿易企業落戶。海南將融合創新發展中醫藥健康旅遊,打造獨特的中醫藥健康旅遊新業態新模式,同時鼓勵增設與休閒度假功能相結合的康養中心,鼓勵旅行社與各類中醫醫療、康養機構合作,在國內外市場推廣。
海南還提出構建高水平中醫藥服務體系,到2022年實現縣辦中醫醫療機構全覆蓋,實現所有社區衛生服務機構、鄉鎮衛生院和70%以上的村衛生室具備中醫藥服務能力。在中藥研究方面,海南將充分利用獨特的熱帶氣候資源,開展南藥、芳香藥、黎藥、海洋藥資源的研究、保護和開發利用工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.